Verrica Pharmaceuticals Inc.
VRCA
$5.14
-$0.12-2.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -27.27% | -30.39% | -34.93% | -8.11% | -51.78% |
| Total Receivables | -36.16% | 38.21% | 6,909.09% | 8,625.00% | 70.17% |
| Inventory | 7.53% | -19.72% | -9.22% | -10.84% | -6.73% |
| Prepaid Expenses | 75.54% | 34.01% | 21.26% | 40.08% | -39.74% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -11.26% | -13.54% | -16.88% | 28.69% | -22.27% |
|
|
|||||
| Total Current Assets | -11.26% | -13.54% | -16.88% | 28.69% | -22.27% |
| Net Property, Plant & Equipment | 4.31% | -28.57% | -27.80% | -55.00% | -54.00% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 257.45% | 696.28% | 626.06% | 407.43% | -17.00% |
| Total Assets | -7.90% | -8.04% | -12.94% | 24.20% | -24.81% |
|
|
|||||
| Total Accounts Payable | -30.93% | 51.98% | 9.28% | 64.08% | 101.83% |
| Total Accrued Expenses | 32.31% | -8.46% | 30.29% | -35.95% | -36.54% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -92.82% | -94.48% | -94.52% | 1,033.42% | 1,167.27% |
| Total Finance Division Other Current Liabilities | 50.60% | -8.25% | -7.95% | -19.91% | -19.10% |
| Total Other Current Liabilities | 50.60% | -8.25% | -7.95% | -19.91% | -19.10% |
| Total Current Liabilities | -23.20% | -44.83% | -43.34% | 37.49% | 45.74% |
|
|
|||||
| Total Current Liabilities | -23.20% | -44.83% | -43.34% | 37.49% | 45.74% |
| Long-Term Debt | -- | -- | -- | -50.08% | -42.51% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -14.17% | -39.57% | -34.49% | -63.77% | -60.33% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 368.49% | 142.86% | 91.31% | -- | -- |
| Total Liabilities | -43.97% | -62.59% | -65.02% | -13.50% | -13.35% |
|
|
|||||
| Common Stock & APIC | 17.71% | 17.59% | 17.66% | 16.76% | 17.44% |
| Retained Earnings | -9.85% | -5.63% | -5.83% | -8.94% | -18.14% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 124.63% | 186.43% | 350.94% | 49.96% | -31.46% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 124.63% | 186.43% | 350.94% | 49.96% | -31.46% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 124.63% | 186.43% | 350.94% | 49.96% | -31.46% |
|
|
|||||